These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2686319)

  • 1. [Clinical results of using Nakom in diseases of the nervous system].
    Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
    Bondarenko ES; Malyshev IuI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
    Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The differentiated treatment of dystonia musculorum deformans in children].
    Mal'mberg SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):33-6. PubMed ID: 7908772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine deficiency syndrome in children with specific reaction to the treatment with levodopa preparations].
    Shoshina LM; Grinio LP; Mineeva MF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):27-32. PubMed ID: 2573987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and treatment of torsion dystonia].
    Barkhatova VP; Markova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
    Markova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholamine excretion in torsion dystonia].
    Barkatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and prognosis of the therapeutic effect of L-DOPA in dystonia musculorum deformans].
    Mel'nichuk PV; Minich LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1002-6. PubMed ID: 484133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catecholamines metabolism in extrapyramidal disorders in children].
    Mosunova TG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1466-9. PubMed ID: 930491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Badalian LO; Amanova ZN; Temin PA
    Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
    Perry D; Birthi P; Salles S; McDowell S
    PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of rigidity and hypokinesis in old age using Sinemet].
    Drobný M; Adamkov J; Svaleková A; Fundárek J
    Cesk Neurol Neurochir; 1979 May; 42(3):195-204. PubMed ID: 455524
    [No Abstract]   [Full Text] [Related]  

  • 14. General discussion of drug therapy in dystonia.
    Adv Neurol; 1976; 14():417-22. PubMed ID: 941782
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatable dystonia presenting as spastic cerebral palsy.
    Fink JK; Filling-Katz MR; Barton NW; Macrae PR; Hallett M; Cohen WE
    Pediatrics; 1988 Jul; 82(1):137-8. PubMed ID: 3380597
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathogenesis of hyperkinesis in children].
    Mel'nichuk PV; Khokhlov AP; Khaĭlova IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1324-8. PubMed ID: 291244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
    Badalian LO; Temin PA; Grinio ZN; Amanova ZN; Sadovskaia IuE
    Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
    [No Abstract]   [Full Text] [Related]  

  • 18. Hereditary progressive dystonia with marked diurnal fluctuation.
    Segawa M; Hosaka A; Miyagawa F; Nomura Y; Imai H
    Adv Neurol; 1976; 14():215-33. PubMed ID: 945938
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
    Panfilova ZP; Kaganova ED; Skubak VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of dystonia musculorum deformans].
    Minich LN
    Zdravookhr Kirg; 1977; (3):30-3. PubMed ID: 22183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.